课题基金 / 基金详情

NEOSTEN AND ALENDRONATE IN THE MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS

NEOSTEN AND ALENDRONATE IN THE MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Neosten 和阿仑膦酸钠治疗绝经后骨质疏松症
批准号:
7606310
负责人:
CRAIG D RUBIN
金额:
$0.57万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2007-09-16

项目摘要

项目成果

CRAIG D RUBIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall objective of this project is to compare the efficacy and safety of intermittent Neosten (slow release sodium fluoride) and continuous Citracal (calcium citrate) therapy with those of Fosamax (alendronate) and calcium citrate in the treatment of postmenopausal osteoporosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEOSTEN AND ALENDRONATE IN THE MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS
  • 批准号:
    7377601
  • 项目类别:
  • 资助金额:
    $3.31万
  • 财政年份:
    2006
  • 负责人:
    CRAIG D RUBIN
  • 依托单位:
NEOSTEN AND ALENDRONATE IN THE MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS
  • 批准号:
    7206000
  • 项目类别:
  • 资助金额:
    $3.93万
  • 财政年份:
    2005
  • 负责人:
    CRAIG D RUBIN
  • 依托单位:
Neosten and Alendronate in the Management of Postmenopausal Osteoporosis
  • 批准号:
    6975052
  • 项目类别:
  • 资助金额:
    $3.59万
  • 财政年份:
    2004
  • 负责人:
    CRAIG D RUBIN
  • 依托单位:
TREATMENT OF SENILE OSTEOPOROSIS--OPEN LABEL CROSSOVER STUDY
  • 批准号:
    6567667
  • 项目类别:
  • 资助金额:
    $32.14万
  • 财政年份:
    2001
  • 负责人:
    CRAIG D RUBIN
  • 依托单位:
海外基金